ENDRA Life Sciences NDRA
NASDAQ NDRA
$5.41 -0.03 (-0.64%)
As of: Aug 27, 2026 · 3:24 PM EDT

ENDRA Life Sciences (NDRA) Invested Capital (2022 - 2023)

ENDRA Life Sciences (NDRA) posted quarterly Invested Capital of $28484.0 for Q4 2023, little changed year-over-year from $28484.0 in Q4 2022, and little changed quarter-over-quarter from $28484.0 in Q3 2023.

ENDRA Life Sciences (NDRA) Invested Capital (2022 - 2023) Analysis & Trends

ENDRA Life Sciences (NDRA) has reported Invested Capital for 2 consecutive years, with $28484.0 the latest figure, recorded in Q4 2023.

  • In Q4 2023, Invested Capital changed 0.0% year-over-year to $28484.0; the TTM figure through Sep 2024 stood at $28484.0 (down 66.67% YoY), while the FY2023 annual figure was $28484.0, changed 0.0% from the prior year.
  • Invested Capital steadied at $28484.0 in Q4 2023 per NDRA's latest filing, from $28484.0 in the prior quarter.
  • Across five years, Invested Capital topped out at $28484.0 in Q4 2022 and bottomed at $28484.0 in Q4 2022.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Invested Cap. (Qtr)
1 Thermo Fisher Scientific 234.15 Bn 230.09 Bn 8.34 Bn 3.37 Bn
2 Danaher 152.10 Bn 147.75 Bn 3.61 Bn 1.41 Bn
3 Natera 48.48 Bn 47.38 Bn 486.15 Mn 80.29 Mn
4 Agilent Technologies 44.35 Bn 42.55 Bn 990.00 Mn 304.00 Mn
5 Iqvia Holdings 43.68 Bn 41.60 Bn 1.44 Bn 2.29 Bn
6 Idexx Laboratories 43.02 Bn 42.83 Bn 779.09 Mn 519.00 Mn
7 Illumina 34.39 Bn 33.22 Bn 770.00 Mn -
8 Mettler Toledo International 28.29 Bn 28.24 Bn 650.22 Mn 67.29 Mn
9 Labcorp Holdings 27.51 Bn 27.37 Bn 1.11 Bn 900,000.00
10 ENDRA Life Sciences 7.16 Mn 1.62 Mn - -

Historic Data

Download Data
DateValue
Dec 31, 2023 28,484.00
Sep 30, 2023 28,484.00
Jun 30, 2023 28,484.00
Dec 31, 2022 28,484.00